← Back to Search

mychoiceTM intervention for Cancer

N/A

Recruiting

Led By Linda Fleisher, PhD, MPH

Research Sponsored by Fox Chase Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

18 years of age or over

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 24 months

Awards & highlights

Study Summary

This trial is a study to see if it is practical and well-liked to give a tool called mychoiceTM to new oncology patients. The study also wants to understand how helpful the tool is

Who is the study for?

This trial is for adult cancer patients who have already had their first medical oncology visit. Participants must be able to speak and read English and have a cell phone number or email on record. It's not for those without a cancer diagnosis or who cannot understand English.Check my eligibility

What is being tested?

The study is testing the mychoiceTM tool, which helps cancer patients discuss clinical trials as treatment options with their providers. The focus is on how feasible and acceptable this tool is when given to new oncology patients.See study design

What are the potential side effects?

Since mychoiceTM is a decision-aid tool rather than a medication, it does not have physical side effects. However, its impact on patient-provider communication and decision-making processes will be closely monitored.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 24 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~24 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability

Effectiveness

Feasibility to disseminate the mychoice tool to patients

Secondary outcome measures

Implementation Factors

Trial Design

1Treatment groups

Experimental Treatment

Group I: mychoiceTM interventionExperimental Treatment1 Intervention

Single arm study - all participants receive mychoiceTM

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Fox Chase Cancer CenterLead Sponsor

227 Previous Clinical Trials

37,338 Total Patients Enrolled

Genentech, Inc.Industry Sponsor

1,541 Previous Clinical Trials

567,943 Total Patients Enrolled

Linda Fleisher, PhD, MPHPrincipal InvestigatorFox Chase Cancer Center

1 Previous Clinical Trials

513 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current number of participants being recruited for this research endeavor?

"Indeed, as stated on clinicaltrials.gov, this study is currently seeking eligible candidates. The initial posting date of the trial was on June 7th, 2023, and it was most recently updated on January 22nd, 2024. To meet its objectives, the clinical trial aims to enroll a total of 200 participants from a single location."

Answered by AI

Is this research study currently accepting new participants?

"Indeed, the information provided on clinicaltrials.gov confirms that this particular clinical trial is actively seeking individuals to participate. The trial was initially posted on June 7th, 2023 and underwent its most recent revision on January 22nd, 2024. This study aims to enroll a total of 200 participants from a single site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

mychoiceTM Implementation With Medical Oncology Patients

Linda Fleisher 2023. "mychoiceTM Implementation With Medical Oncology Patients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06222242.